Categories
- About MIMS Ireland
- New Products
- New Presentations
- New this Month
- Discontinued Products
- New Clinical Evidence
- Clinical Specials
- Irish Medicines Board
- Medicines and Sport
Archives
- December 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- November 2007
- October 2007
Tagcloud
ACE inhibitor, acetylcholinesterase inhibitor, aciclovir, acne, acute coronary syndrome, acute lymphoblastic leukaemia, ADHD, advanced prostate cancer, advanced renal cell carcinoma, advanced soft tissue sarcoma, adverse reaction, agomelatine, agoraphobia, alendronic acid, alfuzosin, algorithm, aliskiren, allergic rhinitis, allopurinol, alpha1-proteinase inhibitor, Alzheimer's, amantadine hydrochloride, ambrisentan, aminosalicylate, amlodipine, amoxicillin, anaemia, angina pectoris, anidulafungin, ankylosing spondylitis, anti-doping, anti-heparin, anti-human thymocyte immunoglobulin, antibacterial, antibiotic, anticoagulant, antidepressant, antineoplastic, antipsychotic, antiretroviral, antiretroviral therapy, anxiety, aromatase inhibitor, asthma, atazanavir, azacitidine, bacterial infections, BCG Vaccine, beclometasone, behaviour disorders, betamethasone, bevacizumab, bicalutamide, bipolar disorder, bisoprolol fumarate, bisphosphonates, black patients, bladder cancer, bowel cleansing, BPH, breakthrough pain, breast cancer, brinzolamide, bronchospasm, budesonide, bulimia nervosa, calcipotriol, calcium, candesartan, Candida albicans, candidiasis, carbetocin, carbidopa, cardiac insufficiency, cardiovascular disease, cefaclor, ceftriaxone, cefuroxime, cephalosporin, cetirizine, CHF, cholecalciferol, chronic constipation, chronic heart failure, Chronic Kidney Disease, chronic myeloid leukaemia, chronic myelomonocytic leukaemia, chronic pain, chronic pulmonary infection, ciprofloxacin, citalopram hydrobromide, clarithromycin, clavulanic acid, clopidogrel, clotrimazole, clozapine, colorectal cancer, contraception, COPD, coronary artery disease, Crohn’s Disease, cystic fibrosis, dabigatran etexilate, daptomycin, darunavir, dasatinib, degarelix, dementia, depression, dermatophytes, dermatophytose, desogestrel, diabetes, diclofenac, dienogest, diphteria, discontinuations, domperidone, donepezil, doxazosin, doxycycline, drospirenone, duodenal ulcer, dyslipidaemia, eczema, eletriptan, emetogenic cancer chemotherapy, enalapril, endocarditis, entacapone, epigastric bloating, epilepsy, epirubicin, epoetin, ErbB2 (HR2) receptors, erythropoiesis-stimulating agents, esomeprazole, estradiol, ethinylestradiol, etravirine, everolimus, exemestane, faecal impaction, famciclovir, fentanyl, fesoterodine, fever, filgrastim, finasteride, fluconazole, fluoxetine, flurbiprofen, fluvastatin, folate, folic acid, follicular development stimulation, follicular lymphoma, follitropin alpha, fosprepitant, fungal infections, gabapentin, gastric cancer, gastric ulcer, gastroduodenal ulcer, gemcitabine, gestodene, gliclazide, glucosamine sulphate, gonorrhoea, GORD, growth failure, H1N1, hayfever, heart failure, heart rate, Helicobacter pylori, hepatic failure, hepatitis, hepatocellular carcinoma, herpes, hip or knee replacement surgery, hip osteoarthritis, HIV, hyaluronic acid, hydrochlorothiazide, Hylan G-F 20, hypercholesterolaemia, hyperlipidaemia, hyperphosphataemia, hypertension, hyperuricaemia, hypoactive sexual desire disorder, ibritumomab, ibuprofen, IGF-1 deficiency, IMB, immunosuppression, indacaterol, indapamide, infections, inflammation, influenza, insomnia, interferon beta-1a, iobetasol, IOP, ipatropium bromide, irinotecan, Irish Sports Council, ischaemic stroke, isotretinoin, ivabradine, Kaposi's sarcoma, kidney cancer, kidney disease, knee osteoarthritis, lacosamide, lamotrigine, lansoprazole, lapatinib, laropiprant, lenalidomide, lercanidipine, leuprorelin acetate, levodopa, levonorgestrel, liraglutide, lisinopril, losartan, lutropin alpha, Lyme disease, macrogol, magnesium, mania, maraviroc, mecasermin, melatonergic, melatonin, meloxicam, memantine, mesalazine, metastatic colorectal carcinoma, metformin, methadone, methylnaltrexone bromide, methylphenidate hydrochloride, mexiletine hydrochloride, micafungin, migraine, mirtazapine, mixed dyslipidaemia, moxifloxacin, multiple myeloma, multiple sclerosis, muscular disorders, myelodysplastic syndromes, myocardial infarction, naloxone, naratriptan, nasal congestion, nausea, nebivolol, nephropathy, neural tube defects, neutropenia, NICE guidelines, nicotine, nicotinic acid, nilotinib, NSCLC, nutrition, OCD, ocular hypertension, olanzapine, olmesartan, omeprazole, ondensetron, open angle glaucoma, opioid addiction, opioid analgesic, opioid-induced constipation, oseltamivir, osteoarthritis, osteonecrosis of the jaw, osteoporosis, otitis, ovarian cancer, overactive bladder syndrome, oxycodone, paclitaxel, pain, pancreatic cancer, pancreatic exocrine insufficiency, pancreatin, panic disorder, panitumumab, pantoprazole, paracetamol, Parkinson’s, partial-onset seizures, patch, pemetrexed, peptic ulcer, perindopril, peripheral arterial disease, peripheral neuropathic pain, pertussis, piperacillin, Pityriasis versicolor, poliomyelitis, post transplantation hyperlipidaemia, post-operative pain, post-traumatic stress disorder, PPIs, pramipexole, pravastatin, pregnancy, pricing policy, primary hypercholesterolaemia, probiotics, prostate cancer, protamine sulphate, Pseudomonas aeruginosa, psoriasis, psychotic disorders, pulmonary arterial hypertension, pulmonary embolism, quetiapine, raltegravir, ramipril, ranolazine, rasagiline, recombinant IGF-1, reflux oesophagitis, renal disease, renin inhibitor, Restless Legs Syndrome, rheumatoid arthritis, ribavirin, ringworm, risedronate sodium, risperidone, rivaroxaban, rivastigmine, romiplostim, ropinirole, rosacea, RTI, S. aureus, salbutamol, sarcoma, saxagliptin, schizophrenia, SCLC, sertraline, sevelamer carbonate, severe pain, simvastatin, sitagliptin, smoking cessation, sodium alginate, solide organ transplantation, sorafenib, sore throat, spasticity, spinal cord injury, sport, sprain, statins, stroke, strontium ranelate, suicide, systemic embolisation, telmisartan, temsirolimus, terbinafine, testosterone, tetanus, thalidomide, thrombocytopenic purpura, thrush, tibolone, timolol, tinea, tiotropium, tipranavir, tizanidine, tobramycin, tocilizumab, topotecan, trabectedin, tramadol, Trichophyton, trimethoprim, trospium chloride, ustekinumab, UTI, vaccine, valaciclovir, valproate, valsartan, varenicline, venlafaxine, venous thromboembolism, venous thrombosis, vildagliptin, vinorelbine, vitamin D, vomiting, WADA, warfarin, wound, zanamivir, zoledronic acid, Zollinger-Ellison syndrome
MIMS Ireland: April 2008
BCG Vaccine SSI – Update
01 April 2008 | Irish Medicines Board
Further to previous articles on BCG Vaccine SSI1, including the outcome of a retrospective review of suspected adverse reactions associated with its use, this month’s article provides an update on experience of adverse reactions reported during 2007, in the context... Read more
Yondelis available for advanced soft tissue sarcoma
01 April 2008 | New Clinical Evidence
PharmaMar is pleased to announce the availability of Yondelis in Ireland. Yondelis (trabectedin) is an antineoplastic agent that is indicated for the treatment of patients with advanced soft tissue sarcoma, after failure of anthracyclines and ifosfamide, or who are unsuited... Read more
Torisel
01 April 2008 | New Products
Company: Wyeth Pharmaceuticals. Legal category: Hospital. Sport permitted. Active ingredient: Temsirolimus 25mg/ml (10mg/ml when diluted). Description: 1.2ml concentrate (clear, colourless to light-yellow solution) and 1.8ml diluent (clear to slightly turbid, light-yellow to yellow solution) for solution for infusion. Presentation: One... Read more
Cubicin
01 April 2008 | New Presentations
Company: Novartis Ireland Ltd. Legal category: Prescription. Sport permitted. Active ingredient: Daptomycin 350mg, 500mg Description: Powder for concentrate for solution for infusion in vial. Presentation: 350mg-1, €79.56; 500mg-1, 113.66. Indications: Complicated skin and soft-tissue infections (cSSTI), right-sided infective endocarditis (RIE)... Read more
Kelo-cote scar gel available
01 April 2008 | New this Month
Pinewood Healthcare Main Distributor of Kelo-cote scar gel in Ireland As part of Pinewood Healthcare’s continued promise to provide the Irish market with quality products at realistic prices, the company is delighted to announce that it is now the sole... Read more
Fental Matrix transdermal patch
01 April 2008 | New Presentations
Company: Rowex Ltd. Legal category: Controlled drug. GMS. Sport prohibited. Active ingredient: Fentanyl 5.78mg (25mcg/hour), 11.56mg (50 mcg/hour), 17.34mg (75mcg/hour), 23.12mg (100mcg/hour). Description: Transparent rounded oblong transdermal patch. Presentation: One pack (5 patches): 25mcg/hour, €30.66; 50mcg/hour, €57.27; 75mcg/hour, €79.83; 100mcg/hour,... Read more
Etrivex
01 April 2008 | New Products
Company: Galderma Ltd. Legal category: GMS. Sport permitted. Active ingredient: Clobetasol propionate 500mcg/g. Description: Viscous, translucent, colourless to pale yellow liquid shampoo with alcoholic odour. Presentation: 125ml, €18.92. Indications: Topical treatment of moderate scalp psoriasis in adults.... Read more
Requip-Modutab
01 April 2008 | New Presentations
Company: GlaxoSmithKline (Ireland) Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Ropinirole 2mg, 4mg, 8mg. Description: Pink (2mg), light brown (4mg) or red (8mg) capsule-shaped, film-coated, prolonged-release tablets, marked GS on one side and either 3V2 (2mg), WXG (4mg)... Read more
Yondelis
01 April 2008 | New Products
Company: Pharma Mar SA. Legal category: Hospital only. Sport permitted. Active ingredient: Trabectedin 0.25mg, 1mg. Description: White to off-white powder for concentrate for solution for infusion. Presentation: 0.25mg vial, €530; 1mg vial, €1994. Indications: Advanced soft tissue sarcoma, after failure... Read more
Ionsys
01 April 2008 | New Products
Company: Janssen-Cilag Ltd. Legal category: Hospital only. Sport prohibited. Active ingredient: Each system contains 10.8mg fentanyl hydrochloride (equivalent to 9.7mg fentanyl), delivering 40mcg fentanyl/dose to a maximum of 3.2mg (80 doses). Description: Iontophoretic transdermal system. Compact electronic controller with two... Read more
Seroquel XR
01 April 2008 | New Presentations
Company: AstraZeneca Pharmaceuticals (Ireland) Ltd. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Quetiapine (fumarate) 50mg, 200mg, 300mg, 400mg. Description: Peach-coloured, yellow, pale yellow, white prolonged released tablets marked with XR and 50, 200, 300, 400 respectively. Presentation: 50mg-60, €68.13;... Read more
Lipaprav
01 April 2008 | New Products
Company: Gerard Laboratories. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Pravastatin sodium 20mg, 40mg. Description: Yellow, indented capsule-shape film-coated tablets with either 20 or 40 on one side. Presentation: 20mg-28, €29.90; 40mg-28, €37.95. Indications: Treatment of primary hypercholesterolemia (HC)... Read more
Mezavant XL
01 April 2008 | New Products
Company: Shire Pharmaceuticals Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Mesalazine 1200mg. Description: Red-brown, ellipsoidal, film-coated, gastro-resistant prolonged release tablet, debossed on one side with S476. Presentation: 60, €77.19. Indications: For the induction and maintenance of clinical... Read more
Pergoveris
01 April 2008 | New Products
Company: Merck Serono. Legal category: Prescription. Sport prohibited for men. Active ingredient: Follitropin alfa (r-h FSH), 150IU (equiv. 11mcg) and lutropin alfa (r-h LH), 75IU (equiv. 3mcg). Description: Powder and solvent for subcutaneous injection. Presentation: 1x vial, €90.98; 10x vials,... Read more
Resdal
01 April 2008 | New Products
Company: Niche Generics Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Risperidone 0.5mg, 1mg, 2mg. Description: Round, slightly convex, pink marbled orodispersible tablets. Presentation: 0.5mg-28, €8.80; 1mg-28, €18.93; 2mg-28, €37.92. Indications: Treatment of schizophrenia. Maintenance treatment in order to... Read more
Combivent Metered Aerosol discontinued
01 April 2008 | Discontinued Products
Boehringer Ingelheim wishes to announce that Combivent (ipratropium and salbutamol) Metered Aerosol will be discontinued in Ireland on June 30th 2008.... Read more
Oramorph Unit Dose Vials discontinued
01 April 2008 | Discontinued Products
Boehringer Ingelheim wishes to announce that Oramorph (morphine sulphate) UDVs10 mg/5 ml, Oramorph UDVs 30 mg/5 ml and Oramorph UDVs 100 mg/5 ml were discontinued on 31st March 2008.... Read more
Premique cycle 10 discontinued
01 April 2008 | Discontinued Products
Wyeth Pharmaceuticals would like to notify you of the discontinuation of Premique Cycle 10. Premique Cycle 10 has been discontinued with immediate effect. This product has not been available on the Irish Market since 2005.... Read more
Retin-A 0.025% Cream discontinued
01 April 2008 | Discontinued Products
Janssen-Cilag Ltd wishes to inform you that Retin-A 0.025% Cream has been discontinued due to commercial reasons.... Read more
Tri-Minulet discontinued
01 April 2008 | Discontinued Products
Wyeth Pharmaceuticals would like to notify you of the discontinuation of Tri-Minulet. Tri-Minulet will be discontinued when current stock is exhausted at the end of 2008.... Read more
Xylocaine 1% with adrenaline discontinued
01 April 2008 | Discontinued Products
AstraZeneca would like to inform you that Xylocaine 1% with adrenaline is being discontinued. It is anticipated that all stocks will be depleted by June 2008.... Read more
